Atlas Trials

Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study

Clinical trial NCT02632747 · COMPLETED

Trial details

NCT number
NCT02632747
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Obesity
Start date
2016-05-10
Primary completion
2017-12-19
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.